GLUE Monte Rosa Therapeutics Inc. (GLUE)

Ownership history in Aisling Capital Management LP  ·  19 quarters on record

AI Ownership Summary

Aisling Capital Management LP reported Monte Rosa Therapeutics Inc. (GLUE) (GLUE) in 19 quarterly 13F filings from 2023 Q4 through 2025 Q4. Peak portfolio weight reached 4.82% in 2025 Q4. The latest visible filing shows GLUE at 4.82% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this GLUE ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Aisling Capital Management LP's position in Monte Rosa Therapeutics Inc. (GLUE), and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

GLUE was reported at 4.82% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
4.82% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Aisling Capital Management LP held GLUE — position size vs. price
% of Fund (quarterly)    GLUE price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED 1,472,331 0% 4.82% $23.1M 2026-02-14 (Est.) $17.92
2025 Q3 UNCHANGED 1,472,331 0% 2.39% $10.9M 2025-11-12 $14.16
2025 Q2 UNCHANGED 1,472,331 0% 1.85% $6.64B 2025-08-13 $4.44
2025 Q1 UNCHANGED 1,472,331 0% 2.37% $6.83B 2025-05-13 $4.04
2024 Q4 UNCHANGED 1,472,331 0% 3.63% $10.22B 2025-02-12 $6.31
2024 Q3 UNCHANGED 1,472,331 0% 2.99% $7.8M 2024-11-13 $8.63
2024 Q2 UNCHANGED 1,472,331 0% 2.38% $5.51B 2024-08-08 $3.98
2024 Q1 UNCHANGED 1,472,331 0% 3.51% $10.4M 2024-05-14 $5.00
2023 Q4 UNCHANGED 1,472,331 0% 2.48% $8.32B 2024-02-07 $4.63
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About Aisling Capital Management LP and GLUE

These are the practical questions this page is built to answer before you even open the full history table.

How long has Aisling Capital Management LP reported owning GLUE?

Aisling Capital Management LP reported GLUE across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported GLUE position in Aisling Capital Management LP's portfolio?

The largest reported portfolio weight for GLUE was 4.82% in 2025 Q4.

What is the latest reported GLUE position on this page?

The most recent filing on this page is 2025 Q4, when Aisling Capital Management LP reported 1,472,331 shares, equal to 4.82% of portfolio, with an estimated market value of $23.1M.

What does the chart on this GLUE ownership page compare?

The chart compares Aisling Capital Management LP's quarterly GLUE portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Aisling Capital Management LP Holdings